Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2021 Filed Feb 26, 2021 21:45 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 2,444 | $60.03 | $146,705.74 |
DisclosureSEC source: 0001384101-21-000022 · wf-form4_161437592691639.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $59.57 to $60.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:45 UTC |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 6,250 | $4.00 | $25,000.00 |
DisclosureSEC source: 0001384101-21-000022 · wf-form4_161437592691639.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. Read SEC document |
| February 25, 2021 Filed May 5, 2021 20:34 UTC Amendment |
EASTHAM KARINDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-21-000072 · wf-form4a_162024685939960.xml · derivative · entry 6 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2022-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| February 25, 2021 Filed May 5, 2021 20:34 UTC Amendment |
EASTHAM KARINDirector
|
SaleCommon Stock | 200 | $61.77 | $12,354.00 |
DisclosureSEC source: 0001384101-21-000072 · wf-form4a_162024685939960.xml · nonDerivative · entry 4 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. Read SEC document |
| February 25, 2021 Filed May 5, 2021 20:34 UTC Amendment |
EASTHAM KARINDirector
|
SaleCommon Stock | 3,606 | $61.09 | $220,298.83 |
DisclosureSEC source: 0001384101-21-000072 · wf-form4a_162024685939960.xml · nonDerivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $60.62 to $61.59. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| February 25, 2021 Filed May 5, 2021 20:34 UTC Amendment |
EASTHAM KARINDirector
|
SaleCommon Stock | 2,444 | $60.03 | $146,705.74 |
DisclosureSEC source: 0001384101-21-000072 · wf-form4a_162024685939960.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $59.57 to $60.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| February 25, 2021 Filed May 5, 2021 20:34 UTC Amendment |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 6,250 | $4.00 | $25,000.00 |
DisclosureSEC source: 0001384101-21-000072 · wf-form4a_162024685939960.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:41 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Tax withholdingCommon Stock | 10,048 | $62.30 | $625,990.40 |
DisclosureSEC source: 0001384101-21-000020 · wf-form4_161437563530725.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,264 F1 · shares: The reporting person is reporting the withholding of 10,048 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 25,000 Performance Stock Units vested on February 24, 2021 and does not represent a sale by the reporting person. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:35 UTC |
Kennedy KeithCOO / CFO
|
Tax withholdingCommon Stock | 11,046 | $62.30 | $688,165.80 |
DisclosureSEC source: 0001384101-21-000018 · wf-form4_161437529534781.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,641 F1 · shares: The reporting person is reporting the withholding of 11,046 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 25,000 Performance Stock Units vested on February 24, 2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 570 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:32 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 39,488 | $62.30 | $2,460,102.40 |
DisclosureSEC source: 0001384101-21-000016 · wf-form4_161437509591066.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,268 F1 · shares: The reporting person is reporting the withholding of 39,488 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 75,000 Performance Stock Units vested on February 24, 2021 and does not represent a sale by the reporting person. Read SEC document |
| January 22, 2021 Filed Jan 25, 2021 22:24 UTC |
JONES EVAN/ FADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-21-000002 · wf-form4_161161348034724.xml · derivative · entry 3 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 22, 2021 Filed Jan 25, 2021 22:24 UTC |
JONES EVAN/ FADirector
|
Exercise / conversionCommon Stock | 5,000 | $2.36 | $11,800.00 |
DisclosureSEC source: 0001384101-21-000002 · wf-form4_161161348034724.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 22:29 UTC |
Ho MarkPrincipal Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001437749-21-001036 · rdgdoc.xml · derivative · entry 4 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 22:29 UTC |
Ho MarkPrincipal Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001437749-21-001036 · rdgdoc.xml · derivative · entry 3 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 22:29 UTC |
Ho MarkPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 7,500 | $6.45 | $48,375.00 |
DisclosureSEC source: 0001437749-21-001036 · rdgdoc.xml · nonDerivative · entry 2 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 22:29 UTC |
Ho MarkPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 45,000 | $4.94 | $222,300.00 |
DisclosureSEC source: 0001437749-21-001036 · rdgdoc.xml · nonDerivative · entry 1 Ho Mark · CIK 0001554165 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 22:03 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,541 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001437749-21-000775 · rdgdoc.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,182 Underlying: Common Stock · 18,541 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 22:03 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 12,177 | $51.26 | $624,179.63 |
DisclosureSEC source: 0001437749-21-000775 · rdgdoc.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,756 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $51.01 to $51.88. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 22:03 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 6,364 | $50.64 | $322,282.51 |
DisclosureSEC source: 0001437749-21-000775 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,933 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $51.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 22:03 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 18,541 | $5.61 | $104,015.01 |
DisclosureSEC source: 0001437749-21-000775 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,354 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · derivative · entry 15 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,723 Underlying: Common Stock · 20,354 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F9 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 400 | $51.20 | $20,479.80 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 9 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,756 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F7 · price: Represents weighted average sales price. Sale prices for the transactions range from $51.05 to $51.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 15,568 | $50.29 | $782,981.66 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 8 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,156 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F6 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.03 to $51.02. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 4,386 | $49.77 | $218,310.96 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,724 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $49.02 to $50.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 20,354 | $5.61 | $114,185.94 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,923 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · derivative · entry 14 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,077 Underlying: Common Stock · 5,923 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F9 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 65,182 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · derivative · entry 13 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,130 Underlying: Common Stock · 65,182 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F9 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 11,497 | $51.56 | $592,750.83 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,756 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $51.32 to $52.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 34,257 | $50.90 | $1,743,838.88 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,253 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.31 to $51.31. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 25,351 | $49.81 | $1,262,713.03 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,510 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $49.30 to $50.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 5,923 | $5.61 | $33,228.03 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 22:11 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 65,182 | $8.86 | $577,512.52 |
DisclosureSEC source: 0001437749-21-000661 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 31, 2020. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:00 UTC |
GORDON KEVIN KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.39 | $0.00 |
DisclosureSEC source: 0001437749-21-000133 · rdgdoc.xml · derivative · entry 4 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2026-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:00 UTC |
GORDON KEVIN KDirector
|
SaleCommon Stock | 5,523 | $49.27 | $272,134.23 |
DisclosureSEC source: 0001437749-21-000133 · rdgdoc.xml · nonDerivative · entry 3 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $49.04 to $49.56. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:00 UTC |
GORDON KEVIN KDirector
|
SaleCommon Stock | 4,477 | $48.62 | $217,664.13 |
DisclosureSEC source: 0001437749-21-000133 · rdgdoc.xml · nonDerivative · entry 2 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,523 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $48.02 to $49.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:00 UTC |
GORDON KEVIN KDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.39 | $73,900.00 |
DisclosureSEC source: 0001437749-21-000133 · rdgdoc.xml · nonDerivative · entry 1 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 22:54 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001437749-20-026177 · rdgdoc.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 22:54 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,313 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001437749-20-026177 · rdgdoc.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,313 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 22:54 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 25,000 | $4.00 | $100,000.00 |
DisclosureSEC source: 0001437749-20-026177 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 22:54 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 6,313 | $2.68 | $16,918.84 |
DisclosureSEC source: 0001437749-20-026177 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $20.21 | $0.00 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · derivative · entry 10 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 3,750 shares Expires 2029-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F8 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,406 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · derivative · entry 9 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,032 Underlying: Common Stock · 4,406 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F7 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,312 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · derivative · entry 8 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,313 Underlying: Common Stock · 5,312 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 6,094 | $57.55 | $350,731.64 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 7 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,312 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $57.31 to $57.90. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 4,279 | $56.86 | $243,284.68 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 6 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,406 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $56.28 to $57.11. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 3,642 | $55.78 | $203,139.83 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 5 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,685 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $55.27 to $56.13. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 3,750 | $20.21 | $75,787.50 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 4 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 4,406 | $5.98 | $26,347.88 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 3 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 5,312 | $9.05 | $48,073.60 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 2 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. Read SEC document |
| December 02, 2020 Filed Dec 5, 2020 00:42 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Tax withholdingCommon Stock | 540 | $55.08 | $29,743.20 |
DisclosureSEC source: 0001437749-20-024903 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,859 F1 · kind: The reporting person is reporting the withholding of 292 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587 and 500 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.